Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain
Status:
Completed
Trial end date:
2020-06-18
Target enrollment:
Participant gender:
Summary
The study is a multicenter, open-label Phase 1b single dose escalation safety study for adult
subjects with intractable pain associated with cancer in any area below the mid-thoracic
level who meet all other eligibility criteria.